GX Pharma Funding: $60M Raised, Investors & Rounds

GX Pharma funding overview

GX Pharma is based in Beijing, China. GX Pharma has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. The round record for GX Pharma runs through 2025; nothing later has been disclosed. Investors on record include Lapam Investment, Samsung Venture Investment Corporation (SVIC), Guofang Innovation, Hankang Venture Capital, Songqing Capital, Jifeng Ventures and 4 others. 10 distinct backers are named across the disclosed rounds.

GX Pharma at a glance

Total raised: $60M
Latest round date: November 2025
Headquarters: Beijing, China
Notable investors: Lapam Investment, Samsung Venture Investment Corporation (SVIC), Guofang Innovation, Hankang Venture Capital, Songqing Capital, Jifeng Ventures, Sino Biopharmaceutical Limited, Decheng Capital

Frequently asked about GX Pharma funding

How much has GX Pharma raised?: GX Pharma has raised $60M in total disclosed funding across the rounds on record.
Who has invested in GX Pharma?: Lapam Investment, Samsung Venture Investment Corporation (SVIC), Guofang Innovation, Hankang Venture Capital, Songqing Capital, Jifeng Ventures are named among the investors backing GX Pharma.
What was the latest GX Pharma funding round?: No round stage has been disclosed for GX Pharma.
Where is GX Pharma based?: GX Pharma is based in Beijing, China.
When did GX Pharma last raise?: The last disclosed GX Pharma round closed in November 2025.

Totals shown for GX Pharma aggregate every disclosed round on file. To see how that compares, browse the companies in Beijing and the investors behind them below.

GX Pharma Funding: $60M Raised, Investors & Rounds

GX Pharma funding overview

GX Pharma at a glance

Frequently asked about GX Pharma funding

Companies related to GX Pharma (19)

Browse related funding lists (4)